469 related articles for article (PubMed ID: 16621429)
21. Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment.
Argon A; Basaran M; Yaman F; Dizdar Y; Sakar B; Camlica H; Bavbek SE; Ozger H; Darendeliler E; Onat H
Jpn J Clin Oncol; 2004 Nov; 34(11):667-72. PubMed ID: 15613556
[TBL] [Abstract][Full Text] [Related]
22. Favorable outcome of Ewing sarcoma family tumors to multiagent intensive preoperative chemotherapy: a single institution experience.
Moschovi M; Trimis G; Stefanaki K; Anastasopoulos J; Syriopoulou V; Koultouki E; Tzortzatou-Stathopoulou F
J Surg Oncol; 2005 Mar; 89(4):239-43. PubMed ID: 15726621
[TBL] [Abstract][Full Text] [Related]
23. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
Yock TI; Krailo M; Fryer CJ; Donaldson SS; Miser JS; Chen Z; Bernstein M; Laurie F; Gebhardt MC; Grier HE; Tarbell NJ;
J Clin Oncol; 2006 Aug; 24(24):3838-43. PubMed ID: 16921035
[TBL] [Abstract][Full Text] [Related]
24. [Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)].
Bacci G; Ferrari S; Rosito P; Barbieri E; Mercuri M; Brach del Prever A; Iantorno D; Forni C; Campanacci M
Minerva Pediatr; 1995 Nov; 47(11):457-69. PubMed ID: 8684341
[TBL] [Abstract][Full Text] [Related]
25. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
Bacci G; Longhi A; Cesari M; Versari M; Bertoni F
Cancer; 2006 Jun; 106(12):2701-6. PubMed ID: 16691623
[TBL] [Abstract][Full Text] [Related]
26. Treatment of femoral Ewing's sarcoma.
Terek RM; Brien EW; Marcove RC; Meyers PA; Lane JM; Healey JH
Cancer; 1996 Jul; 78(1):70-8. PubMed ID: 8646729
[TBL] [Abstract][Full Text] [Related]
27. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy.
Bacci G; Briccoli A; Longhi A; Ferrari S; Mercuri M; Faggioli F; Versari M; Picci P
Acta Oncol; 2005; 44(7):748-55. PubMed ID: 16227167
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis.
Abudu A; Mangham DC; Reynolds GM; Pynsent PB; Tillman RM; Carter SR; Grimer RJ
Br J Cancer; 1999 Mar; 79(7-8):1185-9. PubMed ID: 10098757
[TBL] [Abstract][Full Text] [Related]
30. Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors.
Hunold A; Weddeling N; Paulussen M; Ranft A; Liebscher C; Jürgens H
Pediatr Blood Cancer; 2006 Nov; 47(6):795-800. PubMed ID: 16411206
[TBL] [Abstract][Full Text] [Related]
31. Ewing's sarcoma of the foot.
Adkins CD; Kitaoka HB; Seidl RK; Pritchard DJ
Clin Orthop Relat Res; 1997 Oct; (343):173-82. PubMed ID: 9345223
[TBL] [Abstract][Full Text] [Related]
32. Ewing's sarcoma and the development of secondary malignancies.
Fuchs B; Valenzuela RG; Petersen IA; Arndt CA; Sim FH
Clin Orthop Relat Res; 2003 Oct; (415):82-9. PubMed ID: 14612633
[TBL] [Abstract][Full Text] [Related]
33. Extraskeletal Ewing's sarcoma family of tumours in adults: analysis of 57 patients from a single institution.
El Weshi A; Allam A; Ajarim D; Al Dayel F; Pant R; Bazarbashi S; Memon M
Clin Oncol (R Coll Radiol); 2010 Jun; 22(5):374-81. PubMed ID: 20466282
[TBL] [Abstract][Full Text] [Related]
34. [Long-term results following multidisciplinary treatment of localized Ewing's sarcoma in children and adolescents].
Ullmann C; Beck JD; Holter W; Petsch S; Dunst J; Sauer R; Grabenbauer GG
Strahlenther Onkol; 2008 Mar; 184(3):137-44. PubMed ID: 18330509
[TBL] [Abstract][Full Text] [Related]
35. [The European experience with megadose therapy and autologous bone marrow transplantation in solid tumors with poor prognosis Ewing sarcoma, germ cell tumors and brain tumors)].
Ladenstein R; Gadner H; Hartmann O; Pico J; Biron P; Thierry P
Wien Med Wochenschr; 1995; 145(2-3):55-7. PubMed ID: 7762255
[TBL] [Abstract][Full Text] [Related]
36. Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors.
Krasin MJ; Rodriguez-Galindo C; Billups CA; Davidoff AM; Neel MD; Merchant TE; Kun LE
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):830-8. PubMed ID: 15465200
[TBL] [Abstract][Full Text] [Related]
37. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F
Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175
[TBL] [Abstract][Full Text] [Related]
38. [Prognosis in Ewing sarcoma patients with initial pathological fractures of the primary tumor site].
Hoffmann C; Jabar S; Ahrens S; Rödl R; Rübe C; Winkelmann W; Dunst J; Jürgens H
Klin Padiatr; 1995; 207(4):151-7. PubMed ID: 7564145
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous and subcutaneous Ewing's sarcoma: an indolent disease.
Chow E; Merchant TE; Pappo A; Jenkins JJ; Shah AB; Kun LE
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):433-8. PubMed ID: 10661351
[TBL] [Abstract][Full Text] [Related]
40. [Surgery versus radiotherapy in Ewing's sarcoma with good prognosis. Analysis of the CESS-86 data].
Dunst J; Hoffmann C; Ahrens S; Jürgens H
Strahlenther Onkol; 1996 May; 172(5):244-8; discussion 249. PubMed ID: 8633255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
